Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Legal And Litigation topic
No spam. Unsubscribe anytime.
Council approves Purdue Pharma plan participation and related manufacturer settlements
Summary
In executive session the council voted to accept the Purdue Pharma bankruptcy plan and approve related government‑entity and manufacturer agreements as part of the city’s opioid litigation participation.
Get email alerts on the Legal And Litigation topic
No spam. Unsubscribe anytime.
The City Council took several legal actions following an executive session on Sept. 24 relating to national opioid litigation. The governing body voted to accept the Purdue Pharma bankruptcy plan as presented in U.S. Bankruptcy Court (Southern District of New York) and approved a government‑entity and shareholder agreement and related participation documents. The council also approved combined subdivision participation and releases with a group of secondary manufacturers.
City leaders said the actions align Santa Fe with the national settlement framework that addresses claims against Purdue Pharma and other manufacturers. Council votes were taken in open session following legal discussion; the motions passed on recorded roll calls. The approvals authorize the city to participate in settlement distributions and the associated documents required under the bankruptcy court plan and negotiated manufacturer settlements.
The council’s actions were procedural approvals recommended by the city attorney following confidential attorney‑client discussions; staff indicated the city will continue to monitor the court process and compliance steps required to access settlement funds and execute any implementation agreements.

